FIELD: chemistry; pharmacology.
SUBSTANCE: invention refers to new hyaluronic acid derivatives to be used in medicine and pharmacology. There are disclosed hyaluronic acid derivatives of general formula ,
where R=OH or R1 and ratio R1:OH varies 8:92 to 100:0 , , , ,
, , ,
, ,
, , ,
of lowered biodegradability as compared to natural hyaluronic acid.
EFFECT: production of new hyaluronic acid derivatives.
3 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION OF MODIFIED ARABINOGALACTAN | 2007 |
|
RU2359975C2 |
METHOD FOR PREPARING HEPARIN CONJUGATES | 2005 |
|
RU2298406C2 |
CONJUGATE OF HYALURONIC ACID AND NOVOCAINE WITH AMPHOTERIC PROPERTIES | 2011 |
|
RU2473351C2 |
METHOD FOR PRODUCTION OF MODIFIED DERMATHANE SULFATE | 2005 |
|
RU2318830C2 |
METHOD FOR PRODUCTION OF ALGINIC ACID CONJUGATES | 2005 |
|
RU2283848C1 |
APPLICATION OF CHITOSAN DERIVATIVE FOR SELECTIVE DELIVERY OF MEDICATIONS AND BIOLOGICALLY ACTIVE COMPLEXES | 2013 |
|
RU2561062C2 |
HYALURONIC ACID DERIVATIVE HAVING AMINO ACID AND STERYL GROUP INTRODUCED THEREIN | 2013 |
|
RU2674003C2 |
AGENT FOR HAIR GROWTH STIMULATION | 2012 |
|
RU2505301C2 |
MODIFIED HYALURONIC ACID, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2017 |
|
RU2733444C2 |
DERIVATIVE OF HYALURONIC ACID AND MEDICAL AGENT THAT CONTAINS IT | 2005 |
|
RU2390529C2 |
Authors
Dates
2009-03-27—Published
2007-04-04—Filed